Biotricity EBITDA 2015-2023 | BTCY

Biotricity ebitda from 2015 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Biotricity Annual EBITDA
(Millions of US $)
2023 $-15
2022 $-7
2021 $-11
2020 $-11
2019 $-9
2018 $-7
2017 $-5
2016 $-4
2015 $-5
2015 $-0
2015 $-0
2014 $-0
2014 $-0
Biotricity Quarterly EBITDA
(Millions of US $)
2023-12-31 $-1
2023-09-30 $-2
2023-06-30 $-2
2023-03-31 $-3
2022-12-31 $-4
2022-09-30 $-4
2022-06-30 $-4
2022-03-31 $-3
2021-12-31 $-3
2021-09-30 $-0
2021-06-30 $-1
2021-03-31 $-1
2020-12-31 $-3
2020-09-30 $-3
2020-06-30 $-3
2020-03-31 $-4
2019-12-31 $-2
2019-09-30 $-2
2019-06-30 $-2
2019-03-31 $0
2018-12-31 $-2
2018-09-30 $-2
2018-06-30 $0
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2015-12-31
2015-09-30
2014-09-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.011B $0.010B
Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.024B 20.33
Inspire Medical Systems (INSP) United States $4.855B 0.00
Axonics (AXNX) United States $3.435B 0.00
IRhythm Technologies (IRTC) United States $3.072B 0.00
10x Genomics (TXG) United States $3.022B 0.00
Azenta (AZTA) United States $3.015B 163.85
Olink Holding AB (publ) (OLK) Sweden $2.918B 0.00
Enovis (ENOV) United States $2.779B 20.60
Hims & Hers Health (HIMS) United States $2.603B 0.00
Privia Health (PRVA) United States $2.238B 99.26
Schrodinger (SDGR) United States $1.679B 0.00
Omnicell (OMCL) United States $1.376B 47.56
Phreesia (PHR) United States $1.237B 0.00
Standard BioTools (LAB) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.636B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Talkspace (TALK) United States $0.451B 0.00
Clover Health Investments (CLOV) United States $0.431B 0.00
Health Catalyst (HCAT) United States $0.393B 0.00
Pulmonx (LUNG) United States $0.342B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.300B 0.00
P3 Health Partners (PIII) United States $0.236B 0.00
Outset Medical (OM) United States $0.214B 0.00
Butterfly Network (BFLY) United States $0.201B 0.00
American Well (AMWL) United States $0.150B 0.00
Augmedix (AUGX) United States $0.128B 0.00
TruBridge (TBRG) United States $0.121B 5.17
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.094B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.049B 0.00
Movano (MOVE) United States $0.039B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.017B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Syra Health (SYRA) United States $0.012B 0.00
ETAO (ETAO) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00